KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Debt Ratio (2016 - 2023)

Pacific Biosciences Of California has reported Debt Ratio over the past 13 years, most recently at 0.05 for Q3 2023.

  • For Q3 2023, Debt Ratio changed N/A year-over-year to 0.05; the TTM value through Sep 2023 reached 0.05, changed N/A, while the annual FY2022 figure was 0.1, 4915.96% up from the prior year.
  • Debt Ratio for Q3 2023 was 0.05 at Pacific Biosciences Of California, down from 0.1 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.11 in Q4 2019 and troughed at 0.0 in Q4 2021.
  • A 4-year average of 0.08 and a median of 0.1 in 2022 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: grew 24.02% in 2019 and later soared 4915.96% in 2022.
  • Year by year, Debt Ratio stood at 0.11 in 2019, then plummeted by 98.18% to 0.0 in 2021, then soared by 4915.96% to 0.1 in 2022, then crashed by 48.12% to 0.05 in 2023.
  • Business Quant data shows Debt Ratio for PACB at 0.05 in Q3 2023, 0.1 in Q2 2023, and 0.1 in Q1 2023.